New Tenants & Members

Companies and organizations that have recently participated in Shonan iPark (November 2022 - January 2023).
*Some companies are not listed because they have not yet made an official announcement.




Click here for a list of all tenants and member companies.

Report on Trends In Healthcare Venture Capital Investing

We have published a report on "Trends In Healthcare Venture Capital Investing 2022".

Click here for the digest version.

If you would like to receive the full report (22 pages), please register here.

Download Full Report





iPark Virtual Partnering

iPark Virtual Partnering_HP TOP_banner.jpg

Measures in response to COVID-19

In order to protect the health of residents, members, and visitors, Shonan iPark is taking all possible measures to prevent the spread of COVID-19 infection. We appreciate your corporation.

Read more

Contact: EHS_ipark@takeda.com



【Press Release】 Shonan iPark Outlines New Operational Structure to Provide Scale and Sustainable Long-Term Growth for the Ecosystem


【Press Release】Shonan iPark Announces Finalists of its Second Incubation Program: “Japan Innovation Bloom GRANT CALL 2022”


【Media Coverage】Toshio Fujimoto, General Manager of Shonan iPark, was interviewed by Sankei Newspaper regarding the creation of an effective drug discovery ecosystem in Japan “Reviving the Pharmaceutical Industry: Overcoming Vaccine Defeat”


【Press Release】Shonan iPark Collaborates with Johnson & Johnson Innovation, Janssen Research & Development, LLC, and Takeda Pharmaceutical Company Limited to Launch Japan Innovation Bloom GRANT CALL 2022


【Press Release】Shonan iPark Signs Memorandum of Understanding for Strategic Alliance with Chinese Science Park ‘Suzhou Industrial Park’


【Press Release】ARTham Therapeutics, Inc. Enters into Share Transfer Agreement with Kaken Pharmaceutical Co., Ltd.


【Press Release】iPark Invites Companies to Join Second Phase of “Japan VC Consortium,”a Platform Driving VC, CVC, and Pharmaceutical Company Collaboration


【Article】5th article "Life Science VC Funding in Japan: Signs of Growth & Untapped Opportunities" by Toshio Fujimoto, General Manager of Shonan iPark, has been published on PharmaBoardroom.


【Press Release】Muraoka-Fukasawa District Transforms into Cutting-Edge Center for Health Innovation


【Press Release】New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry


【Press Release】Shonan iPark Signs Partnership Agreement with UK Science Ecosystem, via the National Horizons Centre


【Press Release】Shonan iPark Initiates Pilot Program for Development of iPS Cell Delivery Platform


【Event Report】The summary report of the online event "Innovation and sustainability in Japan’s healthcare system", held on November 25 hosted by The Economist, in which iPark General Manager Fujimoto participated, is now available for download.


Click here to read the white paper "Supporting an Innovative Life Science Ecosystem in Japan" published by The Economist.
*General Manager Fujimoto cooperated in the interview as an expert.